As of Oct. 30, people with dementia in Quebec are allowed to make advance requests for MAiD, before they lose the capacity to provide informed consent.
Melatonin is generally used for eastward travel only, since westward travel is easier to adapt to naturally, making melatonin unnecessary unless travel spans 12 or more time zones.
Proponents of advance requests for MAiD have long argued that patients suffering from neurocognitive illnesses should be able to consent while they’re still competent to do so, an ability they are likely to lose as their disease progresses.
New studies suggest there could be a relationship, presenting the possibility the shingles vaccine could help combat dementia. But evidence to date is far from conclusive.
The Quebec government announced last week that people who have conditions like dementia or Alzheimer’s disease will be able make a request for assisted dying before their mental capacity declines.
